Role of mast cells in early and delayed radiation injury in rat intestine

Radiation Research

Volumn 153, Issue 5 I, 2000, Pages 533-539

  Zheng, Huaien ^a   Wang, Junru ^a   Hauer Jensen, Martin ^a,b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MESSENGER RNA; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; FIBROGENESIS; FIBROSIS; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; INTESTINE WALL; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION ENTEROPATHY; RADIATION INJURY; RAT;

EID: 0034063379     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0533:ROMCIE]2.0.CO;2     Document Type: Article

References (47)

1. S. J. Galli, New concepts about the mast cell. N. Engl. J. Med. 328, 257-265 (1993).
2. S. Watanabe, K. Watanabe, T. Ohishi, M. Aiba and K. Kageyama, Mast cells in the rat alveolar septa undergoing fibrosis after ionizing irradiation. Lab. Invest. 31, 555-567 (1974).
3. E. L. Travis, R. A. Harley, J. O. Fenn, C. J. Klobukowski and H. B. Hargrove, Pathologic changes in the rat lung following single and multiple-fraction irradiation. Int. J. Radiat. Oncol. 2, 475-490 (1977).
4. K. K. Richter, C. W. Langberg, C-C. Sung and M. Hauer-Jensen, Increased transforming growth factor β (TGF-β) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. Int. J. Radiat. Oncol. Biol. Phys. 39, 187-195 (1997).
5. W. K. MacNaughton, K. E. Leach, L. Prud'Homme-Lalonde, W. Ho and K. A. Sharkey, Ionizing radiation reduces neurally evoked electrolyte transport in rat ileum through a mast cell-dependent mechanism. Gastroenterology 106, 324-335 (1994).
6. D. M. Sedgwick and A. Ferguson, Dose-response studies of depletion and repopulation of rat intestinal mucosal mast cells after irradiation. Int. J. Radiat. Biol. 65, 483-495 (1994).
7. Y. Niwa, T. Kasugai, K. Ohno, M. Morimoto, M. Yamazaki, K. Dohmae, Y. Nishimune, K. Kondo and Y. Kitamura, Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood 78, 1936-1941 (1991).
8. M. Morimoto, T. Kasugai, H. Tei, T. Jippo-Kanemoto, Y. Kanakura and Y. Kitamura, Age-dependent amelioration of hypoplastic anemia in Ws/Ws rats with a small deletion at the kinase domain of c-kit. Blood 82, 3315-3320 (1993).
9. K. Horiguchi and T. Komuro, Ultrastructural characterization of interstitial cells of Cajal in the rat small intestine using control and Ws/Ws mutant rats. Cell Tissue Res. 293, 277-284 (1998).
10. M. Hauer-Jensen, L. Poulakos and J. W. Osborne, Effects of accelerated fractionation on radiation injury of the small intestine: A new rat model. Int. J. Radiat. Oncol. Biol. Phys. 14, 1205-1212 (1988).
11. C. W. Langberg, T. Sauer, J. B. Reitan and M. Hauer-Jensen, Tolerance of rat small intestine to localized single dose and fractionated irradiation. Acta Oncol. 31, 781-787 (1992).
12. K. K. Richter, C-C. Sung, C. W. Langberg and M. Hauer-Jensen, Association of transforming growth factor β (TGF-β) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy. Radiother. Oncol. 39, 201-302 (1996).
13. M. Hauer-Jensen, J. W. Theus, J. D. Bradley, M. L. Baker and C. W. Langberg, Localized subclinical radiation enteropathy prolongs intestinal transit time. An experimental study in a rat model. Radiat. Oncol. Invest. 3, 157-166 (1995).
14. C. W. Langberg, J. A. Waldron, M. L. Baker and M. Hauer-Jensen, Significance of overall treatment time for the development of radiation-induced intestinal complications. An experimental study in the rat. Cancer 73, 2663-2668 (1994).
15. M. Hauer-Jensen, T. Sauer, F. Devik and K. Nygaard, Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol. Oncol. 22, 299-303 (1983).
16. L. Matsson, Mast cell heterogeneity in various oral mucosal sites in the rat. Arch. Oral Biol. 37, 445-450 (1992).
17. C. W. Langberg, T. Sauer, J. B. Reitan and M. Hauer-Jensen, Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol. 35, 81-87 (1996).
18. A. J. Baddeley, H. J. G. Gundersen and L. M. Cruz-Orive, Estimation of surface area from vertical sections. J. Microsc. 142, 259-276 (1986).
19. S. W. Qian, P. Kondaiah, A. B. Roberts and M. B. Sporn, cDNA cloning by PCR of rat transforming growth factor β-1. Nucleic Acids Res. 18, 3059 (1990).
20. K. K. Richter, L. M. Fink, B. M. Hughes, C-C. Sung and M. Hauer-Jensen, Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother. Oncol. 44, 65-71 (1997).
21. A. Lopez-de Leon and M. Rojkind, A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J. Histochem. Cytochem. 33, 737-747 (1985).
22. D. J. Farrell, J. E. Hines, A. F. Walls, P. J. Kelly, M. K. Bennett and A. D. Burt, Intrahepatic mast cells in chronic liver diseases. Hepatology 22, 1175-1181 (1995).
23. T. Goto, D. Befus, R. Low and J. Bienenstock, Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am. Rev. Respir. Dis. 130, 797-802 (1984).
24. T. Fukuzumi, N. Waki, Y. Kanakura, J. Nagoshi, S. Hirota, K. Yoshikawa and Y. Kitamura, Differences in irradiation susceptibility and turnover between mucosal and connective tissue-type mast cells of mice. Exp. Hematol. 18, 843-847 (1990).
25. K. Norrby, K. Abok, P. Adamson and B. Forsberg, Radiation effects on mast cells: secretory ability, histamine release and recovery, and cell number. Acta Pathol. Microbiol. Scand. A 92, 417-427 (1984).
26. K. W. Chin and K. E. Barrett, Mast cells are not essential to inflammation in murine model of colitis. Dig. Dis. Sci. 39, 513-525 (1994).
27. A. R. O'Brien-Ladner, L. J. Wesselius and D. J. Stechschulte, Bleomycin injury of the lung in a mast-cell-deficient model. Agents Actions 39, 20-24 (1993).
28. T. Okazaki, S. Hirota, Z-D. Xu, K. Maeyama, A. Nakama, S. Kawano, M. Hori and Y. Kitamura, Increase in mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab. Invest. 78, 1431-1438 (1998).
29. K. Norrby, Evidence of mast-cell histamine being mitogenic in intact tissue. Agents Actions 16, 287-290 (1985).
30. M. F. Graham, D. E.M. Drucker, H. A. Perr, R. F. Diegelmann and H. P. Ehrlich, Heparin modulates human intestinal smooth muscle cell proliferation, protein synthesis, and lattice contraction. Gastroenterology 93, 801-809 (1987).
31. Y. Yamashita, K. Nakagomi, T. Takeda, S. Hasegawa and Y. Mitsui, Effect of heparin on pulmonary fibroblasts and vascular cells. Thorax 47, 634-639 (1992).
32. C. C. Fox, L. M. Lichtenstein and J. K. Roche, Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins. Dig. Dis. Sci. 38, 1105-1112 (1993).
33. I. Leal-Berumen, P. Conlon and J. S. Marshall, IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152, 5468-5476 (1994).
34. S. J. Ruoss, T. Hartmann and G. H. Caughey, Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88, 493-499 (1991).
35. H. Mirza, V. A. Schmidt, C. K. Derian, J. Jesty and W. F. Bahou, Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell α-or β-tryptases. Blood 90, 3914-3922 (1997).
36. M. R. d'Andrea, C. K. Derian, D. Leturcq, S. M. Baker, A. Brunmark, P. Ling, A. L. Darrow, R. J. Santulli, L. F. Brass and P. Andrade-Gordon, Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J. Histochem. Cytochem. 46, 157-164 (1998).
37. J. Wang, H. Zheng, C-C. Sung and M. Hauer-Jensen, The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int. J. Radiat. Oncol. Biol. Phys. 45, 1289-1296 (1999).
38. B. L. Gruber, M. J. Marchese and R. R. Kew, Transforming growth factor-β1 mediates mast cell chemotaxis. J. Immunol. 152, 5860-5867 (1994).
39. Z. Q. Hu, T. Yamazaki, Z. Cai, T. Yoshida and T. Shimamura, Mast cells display natural suppressor activity partially by releasing transforming growth factor beta. Immunology 82, 482-486 (1994).
40. T. A. McCaffrey, D. J. Falcone, D. Vicente, B. Du, S. Consigli and W. Borth, Protection of transforming growth factor β1 activity by heparin and fucoidan. J. Cell. Physiol. 159, 51-59 (1994).
41. J. Taipale, J. Lohi, J. Saarinen, P. T. Kovanen and J. Keski-Oja, Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270, 4689-4696 (1995).
42. R. Eliakim, F. Karmeli, E. Okon and D. Rachmilewitz, Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis. Dig. Dis. Sci. 40, 503-509 (1995).
43. L. E. Donaldson, E. Schmitt, J. F. Huntley, G. F. J. Newlands and R. K. Grencis, A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int. Immunol. 8, 559-567 (1996).
44. R. Malaviya, T. Ikeda, E. Ross and S. N. Abraham, Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381, 77-80 (1996).
45. B. Echtenacher, D. N. Mannel and L. Hultner, Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (1996).
46. S. Komatsu, M. B. Grisham, J. M. Russell and D. N. Granger, Enhanced mucosal permeability and nitric oxide synthase activity in jejunum of mast cell deficient mice. Gut 41, 636-641 (1997).
47. T. Mijatovic, V. Kruys, D. Caput, P. Defrance and G. Huez, Interleukin-4 and -13 inhibit tumor necrosis factor-α mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J. Biol. Chem. 272, 14394-14398 (1997).